Thursday Jan 23, 2025
update Evenity
After more than a year of treading on water of indecision:
I have decided not to take Evenity: Two main reasons.
One is some of the reports I have seen on the web: which I am linking
here.
And, as an older person, there are, I think,
cardiac risks that might not be foreseen,
For example as we age, we all get Arteriosclerosis, can get strokes and so on.
Please realize this is my decision, my choice and I am not
impinging, influencing anyone’s decision.
If you have taken, or are taking this drug, you have
done your due diligence and found that this path was the
right one for you.
I will link to the studies that have helped make up my mind.
I would like to take a few minutes of your time:
to thank the participants who have presented their skepticism
so clearly and articulate
of Big Pharma and the doctors and specialists we see: many of
whom are
not focused on the well being of their patients, but overly
dependent on quick fixes, namely pills.
That is the culture we
live in today. Unfortunately. And it will take brave souls
who highlight these to make a change. Amen.
Some of you know about Martin Shkreli - raising insulin meds from $13.50
to $700.
He was sent to jail, had to pay some fine, he's out of jail now,
was left with a personal fortune of approx 70 Million.
His lawyer is trying to reverse a
condition whereby Shkreli cannot return to the pharma world.
He is working as a software engineer somewhere.
@windyshores
Also, I would like to use this space to say thank to @windyshores
for her kindness and empathy that she shows especially to
new participants, and to others.
In spite of her many health challenges, she exemplifies graciousness
and patience in her communication - which sometimes
is not matched in kind by posts she has lately received.
Here’s link to one study from the Australian Government 2023
https://www.tga.gov.au/news/safety-updates/new-warnings-romosozumab-evenity-cardiovascular-risks
2019 Evenity is not approved: July 1, 2019
https://pharmaphorum.com/news/chmp-says-no-to-amgens-osteoporosis-drug-evenity
“In its assessment, the advisory committee said “as it was unclear why the medicine
appeared to increase the risk of heart and circulatory problems, and there was no
obvious group of patients in whom the risk of these was lower, measures to reduce
the risk could not readily be put in place.”
and
“The CHMP was also not convinced about the efficacy of the drug in
patients with less severe osteoporosis, saying the “benefit was not so convincing”
in this group.”
A Quick Turn About - a few months later Oct 19, 2019
https://pharmatimes.com/news/chmp_u-turn_for_evenity_1313762/
this next one is FDA
https://pharmaphorum.com/news/at-long-last-amgen-ucb-score-fda-okay-for-evenity
Amgen and UCB finally have FDA approval for osteoporosis drug Evenity, two years after
it was turned down by the regulator because of safety concerns.
BTW Amgen will start losing Evenity patent in the U.S.
in 2025… earlier in Europe
Eliminating Evenity, puts me closer to deciding on another anabolic
drug.
I have ‘severe osteoporosis’ - numbers that most health professional
have told me they have never seen.
It’s taken me a over a year to not panic, and try to arrive at what I
think I should be doing.
I’m almost there.
I also reviewed Evenity, and the more I read, the less confident I felt. I am now doing a second course of Forteo. I did 24 month course of it in 2016 after 13 spinal fractures. I have not fractured since, but slight decline in my scores have indicated another course advised. I have not found a lot of data on doing Forteo again, but in my 3 month now and will get another bone density done in a year. They can no longer measure my spine, but my Left Femoral Neck T-Score is -3.3 and my left Hip is T-score -2.8. I am 67, very active Nana of 6 grand children. Walk everyday and grateful to Forteo for returning my quality of life.